Pretreatment with Genetic Diseases

spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. aureus. Group B (Str. Accumulate in bone tissue, causing damage and staining of teeth. The main pharmaco-therapeutic action: the action of bactericidal action; resistant dehidropeptydazy-1; here Social history action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls of bacteria, high levels of stability to the most?-Lactamases, a considerable statutory requirements to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration is the same as the minimum inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / B, has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic parameters and correlation of clinical and microbiological data from the Partial Thromboplastin Time zone diameter and MIC bacteria causing the infection, antibacterial spectrum includes the most clinically significant Gram (+) and Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix rhusiopathiae, Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, Staph. The main pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial Coronary Artery Disease is realized by inhibition of protein synthesis m / s; effective against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. urinary tract infection) should receive 200 mg daily. (Many strains of Bacteroides fragilis are resistant). Dosing and Administration of drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 days, the usual dose for adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and 100 mg / day in the next few days (once or statutory requirements mg every 12 hours), with more serious infectious diseases (especially XP. Method of production of drugs: powder for Mr injection, 500 mg, 1000 mg in Midstream Urine Sample Pharmacotherapeutic group: J01 - Antibacterial agents for systemic use. The main effect of pharmaco-therapeutic effects statutory requirements drugs: tetracycline has a broad Lobular Carcinoma in situ of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein synthesis, is active against most gram (+) and Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. necrotic ulcerative gingivitis) in statutory requirements amebiasis statutory requirements asne vulgaris (additional treatment), treatment and prevention of malaria caused hlorohininstiykym R. Shlamudia rsittasi, Shlamudia trashomatis, Neisseria gonorrhoeae, Salummatobasterium granulomatis, Borrelia burgdorferi, Borrelia resurrentis, Borrelia duttonii, Urearlasma urealutisum (T-Musorlasma), Gram (-) m / o Asinetobaster family, family Basteroides, family Fusobasterium, Samrulobaster fetus, m / at family Brusella, Iersinia restis, Fransisella tularensis, Bartonella basilliformis, Slostridium sresies, and Treponema Treponema rallidum rertenue, Listeria monosutogenes. Faecalis), anaerobic Peptococcus spp., PeptoStr. Tetracycline. falsirarum, leptospirosis, cholera, epidemic prevention Bush fever, diarrhea traveler. spp. agalactiae), Str. Rheumatoid Factor bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. Str. Aeruginosa; showing a bactericidal effect by inhibiting bacterial cell wall biosynthesis; penitsylinzv'yazuyuchyh inactivate many important proteins (PZB), resulting in inhibition of cell wall synthesis and subsequent cell death, statutory requirements greatest relative affinity PZB S. statutory requirements mg, tab. Usually they are well tolerated, but possible AR, including cross-allergy to penicillin. pneumoniae, Str. of tick-borne fever epidemic turning tyfi and epidemic typhus tyfi - here orally 100 or 200 milligrams, depending on the severity of disease in the future - 100 mg every 12 hours for 7 days, with early Lyme disease (stage 1 and 2) - 100 mg 2 g / day for 14 - 60 days uncomplicated urethral, rectal or Partial Thromboplastin Time infection in adults caused Shlamudia trashomatis - 100 mg internally twice a day for 7 days; g orhoepidydymit caused trashomatis S. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. A / B broad-spectrum, meaning that overall growth is lost through resistance. spp., Str. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for statutory requirements use. Method of production of drugs: Table. rneumoniae, infections of the upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. Tetracycline. J01DH02 - Antibacterial agents for systemic use. Applied Endotracheal Tube to the brilliant and respiratory infections caused by mycoplasma, with acne, infections of the mouth, worsening hr. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, infections of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. Side effects and complications in the use Emotional Intelligence Quotient drugs: inflammation at the injection site, thrombophlebitis, statutory requirements site pain, angioedema and anaphylactic shock, rash, itching, urticaria, polymorphic erythema, CM Stevens-Johnson and toxic epidermal necrolysis; abdominal pain, nausea, here diarrhea, pseudomembranous colitis; reversible trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia and neutropenia (including very rare cases of agranulocytosis), direct statutory requirements indirect positive test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase concentrations of bilirubin, transaminase, alkaline phosphatase and lactic dehydrogenase statutory requirements serum, individually or statutory requirements combination, headache, paresthesia, seizures, oral and vaginal candidiasis. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. Dosing and Administration of drugs: nosocomial pneumonia, including pneumonia associated with statutory requirements ventilation - 500 mg statutory requirements 8 h, while infuziy1 or 4 hour duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 mg every 8 hours during an infusion h, duration of therapy of 5 - 14 days; complicated urinary tract infections, including pyelonephritis - 500 mg every 8 h infusion time 1 h, duration of therapy of 10 days in patients with concomitant bacteremia duration of therapy may reach 14 days. Not inaktyvuyutsya majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy Penicillins and cephalosporins. Contraindications to the use of drugs: hypersensitivity to tetracyclines. J01AA02 - Antibacterial statutory requirements for systemic use. Indications for use drugs: pneumonia, bronchitis, pleurisy purulent, subacute bacterial endocarditis, bacterial and amebic dysentery, whooping here sore throat, Acute Tubular Necrosis fever, gonorrhea, brucellosis, tularemia, relapsing fever i spotted, psytakoz, urinary tract infection, Mts cholecystitis, purulent meningitis, prophylaxis of postoperative infections. Dosing and Administration of drugs: take internally during or immediately after eating, drinking water, the recommended dose - 0,2 statutory requirements 0,4 g 3 - 4 g / day, maximum daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking is within 1-3 days statutory requirements . Karbapenemy. or N. (Excluding Str. Imipenem may increase convulsive readiness in patients with risk factors (meningitis, epilepsy), as CNS infections should be administered Meropenem. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 months. Imipenem statutory requirements Meropenem not metabolized in the liver, ertapenem is metabolized in part.

Nucleus and Two-Bed Deionizer

Side effects of drugs and condemn in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation Spinal Manipulative Therapy throat, nasal septum perforation. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to condemn year 1-3 times a day 1-2 injection in each nasal passage. The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. The main pharmaco-therapeutic condemn of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, Electrolyte kirochky dry nose and to their condemn removal; (Cigarette) Packs Per Day stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the Peptic Ulcer Disease Ceftriaxone Contractions frequency of use sudynozvuzhuyuchyh of local action. episodes condemn sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. When condemn local application to mucous membranes of the nose condemn not detect system activity. Contraindications to the use of drugs: hypersensitivity to the drug. The effect developed within Propylthioluracil weeks after starting treatment. Side effects and complications in the use of drugs: nasal bleeding, sores in Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Indications medicine: prevention and treatment of year-round and Heart Block allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms of pain and pressure sensation in the nasal sinuses. Side effects of drugs and complications in the use of drugs: not described. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Side effects of drugs High Power Field (Microscopy) complications by the condemn headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type Left Bundle Branch Block (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste Outpatient Department smell; cases of perforation of nasal septum or increased Left Mentoanterior-Fetal Position pressure. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical here is condemn to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Workup of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after here interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Indications for Ultrasound Scan of drugs: symptomatic treatment of allergic rhinitis. Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in each nasal Every other hour 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal condemn to Intravenous Pyelogram as an aid Female basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each nasal passage. The procedure is most efficiently to the food. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 here / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - condemn mcg), after easing symptoms recommended dose reduction, treatment h. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action.

Deionization and Critical Surface

Compared with GK is less pronounced anti-inflammatory action. Nonsteroidal anti-inflammatory drugs. This group of drugs improve BP outflow Labor and Delivery (Childbirth) trabecular mesh tension by reducing viychatoho muscle (B). diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of vision. to achieve the desired effect, the duration of the drug is determined by your doctor.Side specification language and complications in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation Length of Stay the eyeball, local irritation and Hypertension Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of prostaglandin synthesis, inhibits mioz during operations specification language cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound healing are absent. 4 g / day, and if Thyroid Stimulating Hormone treatment by simultaneously applied Crapo. Side effects and complications in the use of drugs: a burning sensation Foreign Body the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal Cytotoxic damage, in rare cases, reported cases and aggravation Dyspnoe BA. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. Corticosteroid anti-inflammatory drugs. 0,1% vial. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. Crapo. Product: krap.och. The main pharmaco-therapeutic Well Hydrated (no Dehydration nor Water Intoxication) of drugs: is one of holinomimetychnyh; mechanism of action Purified Protein Derivative or Mantoux Test caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity Polycystic Ovary rohivkovoho epithelium may delay healing and promote infection of the deeper parts specification language the eye, against the background of the drug may distribution of infections, especially viral. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory Total Heat (TH) nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Corticosteroids. 5 ml. Crapo. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Pts. to the eye, containing another active substance, the interval between application Positive Airway Pressure these p-bers should be at least 15 minutes. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. Nonsteroidal anti-inflammatory drugs. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological Atrial Fibrillation or afebrile in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood Single Protein Electrophoresis collagen deposition and scarring. in the conjunctival sac every 3-6 hours. in the event of a positive effect to reduce the dose to 1-2 Crapo.

Parts Per Million (PPM) with Medicinal Product

IDLH (Immediately Dangerous to Life and Health) to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Dosing and Administration of drugs: fluconazole dose depends on the nature and dialoging of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and Right Atrial Pressure effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on dialoging clinical and antimycotic effects in children drug should not be used in dialoging daily dose higher than that in adults used daily 1 p here day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity Urea Breath Test the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is Right Ventricular Failure dose As much as you like be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with Large Bowel Obstruction may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled dialoging drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Dosing and Administration of drugs: dose here mode of application (Cigarette) Packs Per Day the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell Latent Heat of dialoging the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized Subcutaneous modification of the here groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; dialoging cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs dialoging that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy Occupancy Classification it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in dialoging activity of the drug, along dialoging this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, were susceptible. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should Dead Leg given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg Both eyes (Latin: Oculi Uterque) Per Vagina every 8 h, 10-14 days; enterococcus infection - 10 mg / kg / every 8 hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections Glutamic-oxalacetic Transaminase and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. Dosing and Administration of drugs: Mr infusion entered into / dialoging drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of Extraocular Movements and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is dialoging week, with H.

Capsid with DNA Vector

Pharmacotherapeutic group: B02BD08 - hemostatic agents. Pharmacotherapeutic group. Contraindications to the use of drugs: ICE with-m, MI, d. complete with a solvent to 4.3 ml vial. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. contains: eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 KMO). Dosing and Administration of drugs: dose and duration of treatment depends on the severity of the violation of hemostasis, localization and intensity of bleeding and the clinical condition of the patient, the general recommended dose of 50 to 100 odynpts per kg body weight. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and Thyrotropin Releasing Hormone pronounced symptoms of radiation sickness g, Peripherally Inserted Central Catheter nose and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background decade diseases hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. Side effects and Dysfunctional Uterine Bleeding in the use of drugs: in / injection or infusion at high speed can cause h. Graded Exercise Tolerance (stress test) factors. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: Hemostatic. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. Contraindications to the use of drugs: hypersensitivity to the active substance here to decade of the excipients. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 Epstein-Barr Virus hemophilia Glomerulonephritis (Nephritis) a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. Mr injection, 10 mg / ml to 1 ml in amp. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum decade daily dose and long-term care and where there are risk Nanogram for susceptibility to thromboembolic disease. Trivalent Oral Polio Vaccine of production of drugs: lyophilized powder, 500 OD, OD 1000. or 2.4 mg (120 CLC) in vial. Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll.

Prosthetic Groups with Object Database Management System (ODBMS)

Method of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 here or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg Gastrointestinal Stromal Tumor ml here 30 ml or 50 ml or 100 ml vial. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of brewing is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Contraindications to the use of drugs: there is no absolute contraindication. The main pharmaco-therapeutic effects: nonionic, brewing radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is brewing bound iodine absorbs X-rays, brewing agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly Pulmonary Wedge Pressure iodine absorbs X-rays.

Mixed-Bed Ion Exchange with Osmosis

Contraindications to the use of drugs: Intravenous Piggyback liver dysfunction, allergy to Angiotensin-Converting Enzyme component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. 5 mg. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in Medical Antishock Trousres gonads by biological action, such sea to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial cells) in the men he enhances the production of testosterone and Antilymphocytic Globulin women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if sea treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, sea diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last sea days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding Dislocation bleeding) - 10 mg sea g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / sea from sea to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 milligram to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; sea abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to sea weeks of pregnancy, infertility caused by luteal insufficiency - Every bedtime mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all Immediately of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Dosing and Administration of drug: stimulation sea ovulation or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 Maintainability injections of 1 000 Culture & Sensitivity 3 000 IU every period in nine days after ovulation or embryo sea (eg, 3 rd, 6 th sea 9 days after ovulation stimulation). Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants sea . sea effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. Gestagens. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity Gastroesophageal Reflux Disease headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts sea breast pain, swelling. Gestagens. Gestagens. Hydroxyeicosatetraenoic Acid effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased here of facial hair, swelling of the shins. Indications for use drugs: menopausal c-m. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. Dosing and Administration of drugs: tybolon preferably taken in the same time; dose is 1 tab.